Baudax Bio Provides Commercial and Corporate Update

Oct 20, 2020 7:00am EDT

Baudax Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Oct 02, 2020 4:05pm EDT

Baudax Bio to Present at Oppenheimer Fall Healthcare Life Sciences & Medtech Summit

Sep 18, 2020 7:35am EDT

Baudax Bio Awarded Group Purchasing Agreement with Premier Inc. for ANJESO®

Aug 25, 2020 4:05pm EDT

Baudax Bio Appoints Arnold Baskies, M.D. and Andrew Drechsler to Board of Directors

Aug 20, 2020 5:57pm EDT

Baudax Bio Reports Second Quarter 2020 Financial Results

Aug 10, 2020 7:15am EDT

Baudax Bio to Report Second Quarter 2020 Financial Results and Host Conference Call and Webcast on August 10, 2020

Aug 06, 2020 4:05pm EDT

Baudax Bio Secures Permanent J-Code (J1738) for ANJESO® from Centers for Medicare and Medicaid Services

Aug 06, 2020 7:00am EDT

Baudax Bio Announces Presentation of New Phase IIIb ANJESO® Data at the American Society of Colon and Rectal Surgeons 2020 Annual Scientific Meeting

Jul 30, 2020 4:05pm EDT

Baudax Bio Secures Pharmacy Supplier Agreement with Vizient Inc. for ANJESO®

Jul 20, 2020 7:00am EDT